BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26550538)

  • 1. Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma.
    Sachpekidis C; Hillengass J; Goldschmidt H; Mosebach J; Pan L; Schlemmer HP; Haberkorn U; Dimitrakopoulou-Strauss A
    Am J Nucl Med Mol Imaging; 2015; 5(5):469-78. PubMed ID: 26550538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
    Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of
    Sachpekidis C; Hillengass J; Goldschmidt H; Anwar H; Haberkorn U; Dimitrakopoulou-Strauss A
    Am J Nucl Med Mol Imaging; 2017; 7(4):148-156. PubMed ID: 28913153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined
    Sachpekidis C; Goldschmidt H; Kopka K; Kopp-Schneider A; Dimitrakopoulou-Strauss A
    EJNMMI Res; 2018 Apr; 8(1):28. PubMed ID: 29633046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
    Ponisio MR; McConathy J; Laforest R; Khanna G
    Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can
    Sachpekidis C; Kopp-Schneider A; Merz M; Jauch A; Raab MS; Goldschmidt H; Dimitrakopoulou-Strauss A
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Aiello M; Alfano V; Salvatore E; Cavaliere C; Picardi M; Della Pepa R; Nicolai E; Soricelli A; Vella A; Salvatore M; Mascalchi M
    EJNMMI Res; 2020 Aug; 10(1):91. PubMed ID: 32761394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.
    Sachpekidis C; Thieke C; Askoxylakis V; Nicolay NH; Huber PE; Thomas M; Dimitrakopoulou G; Debus J; Haberkorn U; Dimitrakopoulou-Strauss A
    Am J Nucl Med Mol Imaging; 2015; 5(2):127-42. PubMed ID: 25973334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.